[et_pb_section bb_built=”1″][et_pb_row][et_pb_column type=”4_4″][et_pb_text _builder_version=”3.13.1″]

The pancreas is a very important organ for our body, responsible for producing the enzymes that help digestion and hormones that regulate the metabolism of sugar.

Cancer of this organ is usually detected too late, expands rapidly and has a lethal prognosis.

In the early stages this cancer does not present symptoms, so its diagnosis is difficult, however in some cases when it is in an advanced stage, the patient may have yellowish skin, weight loss and appetite, among others.

In order to diagnose pancreatic cancer in advance, a group of scientists from Brazil manufactured a device, capable of detecting the biomarker of pancreatic cancer in real samples of blood and tumor cells in a category of clinical importance.

This device is composed of two nanometer-scale plates, with proteins synthesized by pancreatic cells and the bile duct, it is used as a biomarker of pancreatic cancer, since its concentration is high in people suffering from pancreatic cancer.

The performance of this device in the detection of the CA19-9 protein was competitive with respect to similar and more sophisticated sensors, including others previously developed by the same group of scientists.

After performing different experiments, the device showed its great power and reliability in the confirmation of positive results, ruling out misdiagnoses. In addition, it is added that it is produced at a very low cost.

Treatment for pancreatic cancer may involve surgical removal of the pancreas, along with radiation therapy and chemotherapy.

These and other innovations are now possible in Pharmamedic.

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]